- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Obesity & Type 2 Diabetes: An Expert Discussion
In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
In episode 25 of the Patient Care Online Primary Viewpoints podcast, Shagun Bindlish, MD, and Peminda K. Cabandugama, MD, discuss obesity and type 2 diabetes (T2D), including the most significant complications associated with these conditions that a primary care clinician is likely to encounter, how to best treat patients with obesity and T2D, and their suggestions to primary care clinicians on managing this patient population.
Dr Bindlish is a board member of the American Diabetes Association and medical director at One Medical in Dublin, California.
Dr Cabandugama is the director of Digital Obesity at the Cleveland Clinic and a member of the Obesity Medicine Association.
The Primary Viewpoints podcast features informative conversations with health care experts, opinion leaders, and practicing physicians, about what impacts primary care medicine today. Click here to subscribe on your favorite streaming service.
Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial
August 26th 2025Patients taking orforglipron achieved significant weight loss, hemoglobin A1c reduction, and cardiometabolic benefits in the phase 3 ATTAIN-2 study, supporting upcoming global regulatory submissions.
